Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multi-site, Randomized, Double-blind, Vehicle-controlled Study of the Efficacy and Safety of Squaric Acid Dibutyl Ester (SADBE) in Subjects With Recurrent Herpes Labialis - Single Versus Two-dose Arm Application

NCT02965781 is registered in ClinicalTrials.gov with Squarex, LLC as lead sponsor.

NCT NCT02965781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02965781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multi-site, Randomized, Double-blind, Vehicle-controlled Study of the Efficacy and Safety of Squaric Acid Dibutyl Ester (SADBE) in Subjects With Recurrent Herpes Labialis - Single Versus Two-dose Arm Application
Lead sponsor
Squarex, LLC
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 2016
Completion date
December 20, 2018
Enrollment
139 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cold sore, herpes labialis